11-125894007-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_031307.4(PUS3):c.1224G>A(p.Met408Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000177 in 1,614,182 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_031307.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PUS3 | NM_031307.4 | c.1224G>A | p.Met408Ile | missense_variant | 4/4 | ENST00000227474.8 | NP_112597.4 | |
HYLS1 | NM_001134793.2 | c.-26+2535C>T | intron_variant | ENST00000425380.7 | NP_001128265.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PUS3 | ENST00000227474.8 | c.1224G>A | p.Met408Ile | missense_variant | 4/4 | 1 | NM_031307.4 | ENSP00000227474.3 | ||
HYLS1 | ENST00000425380.7 | c.-26+2535C>T | intron_variant | 3 | NM_001134793.2 | ENSP00000414884.2 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152178Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000445 AC: 112AN: 251446Hom.: 0 AF XY: 0.000353 AC XY: 48AN XY: 135898
GnomAD4 exome AF: 0.000168 AC: 246AN: 1461886Hom.: 2 Cov.: 33 AF XY: 0.000150 AC XY: 109AN XY: 727246
GnomAD4 genome AF: 0.000256 AC: 39AN: 152296Hom.: 1 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74466
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 14, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at